Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development

Public

Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development

N

Shared by NobleBlocks on Sep 19, 2018 • 12:00 AM UTC

Authors:

Guoshuang Shen

,

Fangchao Zheng

,

Dengfeng Ren

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!

Publication Date: Sep 19, 2018 • 12:00 AM UTC

DOI:10.1186/s13045-018-0664-7

No figures available

Scan for Errors

Scan for EDDII

Summarise

Generate Podcast

Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development | NobleBlocks